These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11650075)

  • 1. The case for per patient payments.
    Lewis JP
    IRB; 1988; 10(5):9. PubMed ID: 11650075
    [No Abstract]   [Full Text] [Related]  

  • 2. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 3. Is post-marketing drug follow-up research or advertising?
    Weiss GB; Winslade WJ
    IRB; 1987; 9(4):10-1. PubMed ID: 11649947
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilemmas in paying for clinical research: the view from the IRB.
    Lind SE
    IRB; 1987; 9(2):1-5. PubMed ID: 11649900
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug trials hide conflicts for doctors.
    Eichenwald K; Kolata G
    N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
    [No Abstract]   [Full Text] [Related]  

  • 6. Playing roulette with experimental drugs.
    Budiansky S
    US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing new drugs: joining a study can be rewarding -- but risky How to find -- and survive -- a clinical trial.
    Consum Rep; 1998 Dec; 63(12):64-5. PubMed ID: 11660639
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 11. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical considerations in informed consent for potential future use of human tissue samples.
    Adams M; Prentice ED; Oki GS
    IRB; 1996; 18(2):6-7. PubMed ID: 11654756
    [No Abstract]   [Full Text] [Related]  

  • 13. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
    Siris ES; Burrell CD
    IRB; 1983; 5(6):1-5. PubMed ID: 11649526
    [No Abstract]   [Full Text] [Related]  

  • 14. Payments to doctors and the responsibilities of ethics committees.
    Diamond AL; Robinson K; Cousins J
    Br Med J (Clin Res Ed); 1984 Jan; 288(6413):322-3. PubMed ID: 11658728
    [No Abstract]   [Full Text] [Related]  

  • 15. Money is putting people at risk in biomedical research.
    Andrews LB
    Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
    [No Abstract]   [Full Text] [Related]  

  • 16. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

  • 17. The paradoxical case of payment as benefit to research subjects.
    Macklin R
    IRB; 1989; 11(6):1-3. PubMed ID: 11650284
    [No Abstract]   [Full Text] [Related]  

  • 18. Policies and quality assurance in the pharmaceutical industry.
    Shamoo AE
    Account Res; 1991; 1(4):273-84. PubMed ID: 11651459
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflict of interest in human research ethics.
    Jones DJ
    NCBHR Commun; 1995; 6(2):5-10. PubMed ID: 11654611
    [No Abstract]   [Full Text] [Related]  

  • 20. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.